Use of intralesional interferon-α for the treatment of recalcitrant oral warts in patients with AIDS: A report of 4 cases

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 92, Issue 6, 2001, Pages 617-622

  Lozada Nur, Francina ^a   Glick, Michael ^b   Schubert, Mark ^c   Silverberg, Ivan ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RECOMBINANT INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; HOMOSEXUALITY; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; MALE; MOUTH DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; VERRUCA VULGARIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIVIRAL AGENTS; HOMOSEXUALITY, MALE; HUMAN; INJECTIONS, INTRALESIONAL; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGE; MOUTH DISEASES; WARTS;

EID: 0035654564     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.118905     Document Type: Article

References (23)

1. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequence of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. J Virol 1995;69:3074-82.
2. Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, et al. Virologie, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:314-19.
3. Al-Bakkal G, Ficarra G, McNeill K, Eversole LR, Sterrantino G, Birek C. Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:197-208
4. Franceschi S, Muñoz N, Bosch XF, Snijders PJ, Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996;5:567-75
5. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90:1626-36.
6. Mork J, Lie KA, Glattre E, Clark S, Hallmans G, Jellum E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344:1125-31.
7. Drake LA, Ceilley RI, Cornelison RL, Dobes WL, Dorner W, Goltz RW, et al. Guidelines of care for warts: Human papilloma virus. J Am Acad Dermatol 1995;32:98-103.
8. Conant M. Immunomodulatory therapy in the management of viral infections in patients with HIV-infection. J Am Acad Dermatol 2000;43:S27-30.
9. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr. Treatment of genital warts with an immuneresponse modifier (imiquimod) J Am Acad Dermatol 1998;38:230-9.
10. Edwards L. Imiquimod in clinical practice. J Am Acad Dermatol 2000;43:S12-7.
11. Barbuto AJ, Hersh E. Role of cytokines in cancer therapy. In: Aggarwal B, Puri R, editors. Human cytokines: their role in disease and therapy. Oxford: Blackwell Science, Pty Ltd; 1995. p. 503-24.
12. Epstein JB, Lozada-Nur F, McLeod WA, Spinelli J. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine. Cancer 1989;64:2424-30.
13. Syed TA, Cheema KM, Khayyami M, Ahmad SH, Ahmad S, Ahmad SA. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. A placebo-controlled, double-blinded, comparative study. Dermatology 1995;191:129-32.
14. Lozada-Nur F, Silverman S Jr, Migliorati C, Conant M, Abrams D, Volverding PA, et al. The diagnosis of AIDS and AIDS related complex in the dental office: Findings in 171 homosexual males. CDA J 1984;12:21-5.
15. Silverman S Jr, Migliorati C, Lozada-Nur F, Greenspan D, Conant MA. Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males. J Am Dent Assoc 1986;112:187-92
16. Patton L, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence on oral manifestations of human immunodeficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:299-304.
17. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001;357:1411-2.
18. Garden JM, O'Banion M, Shelnitz LS, Pinski KS, Bakus AD, Reichmann ME, et al. Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. JAMA 1988;259:1199-1202.
19. Tyring SK. Human papillomavirus infections: epidemiology, pathogenesis, and host immune response. J Am Acad Dermatol 2000;43:S18-26.
20. Warren MK, Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 1986; 137:2281-5.
21. Cantell K, Hirvonen S, Kauppinen HL, Myllyla G. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol 1981;78:29-38.
22. Shirafuji N, Matsuda S, Ogura H, Tani K, Kodo H, Ozawa K, et al. Granulocyte colony stimulating factor stimulates human mature neutrophilic granulocytes to produce interferon alpha. Blood 1990;75:17-9.
23. Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:57-68.